Mindestbestellung 115 CHF Kostenlose Lieferung ab 235 CHF Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 235 CHF Aktionen

Cathinon-Derivate

α-PHiP alpha-PiHP

α-PHiP alpha-PiHP. CAS-Nummer: 2181620-71-1. Summenformel: C16H23NO. Molekulargewicht: 245.36 g/mol. Chemische Parameter stehen in der Tabelle der Produkteigenschaften.

Chemischer Name
4-methyl-1-phenyl-2-pyrrolidin-1-ylpentan-1-one
Weitere Namen
alpha-PiHP, α-PHiP
CAS-Nummer
2181620-71-1
Summenformel
C16H23NO
Molekulargewicht
245.36 g/mol
Chemische Form
Erscheinungsbild
Herkunftsland
Zustand
Neu

10.00 CHF

Portion

10.00 CHF / 1 g 10.00 CHF

  • Externe Laborprüfung (≥98%) sowie vollständiges CAS-Eigenschaftsblatt auf der Produktkarte.
  • Diskretes, neutrales Paket (Packstation / Kurier) oder fertige Dead-Drop-Abholung in Ihrer Stadt.
  • Kauf ohne Pflichtregistrierung (BTC / XMR) · 24/7 Live-Chat (14:00–22:00 Schicht unserer Chemikerin).

Referenzinformationen

4,8 (27)

α-PHiP alpha-PiHP gehört zur Kategorie „Cathinon-Derivate“. Chemischer Name (IUPAC): 4-methyl-1-phenyl-2-pyrrolidin-1-ylpentan-1-one. Weitere Namen: alpha-PiHP, α-PHiP, αPHiP, α PHiP, a-PHiP, aPHiP, a-PiHP. CAS-Nummer: 2181620-71-1. Summenformel: C16H23NO. Molekulargewicht: 245.36 g/mol.

Verfügbare Portionsgrößen auf dieser Karte bei RC Drogen Schweiz: 1 g, 5 g, 10 g, 25 g, 50 g, 100 g, 1000 g. Bestellungen werden per Kurier, Paketstation oder über fertige Dead-Drop-Dead Drops auf der Karte abgewickelt. Zahlung mit Bitcoin (BTC) und Monero (XMR). Cathinon-Derivate: 2-MMC 2-Methylmethcathinon, 3-CMC Clofedron, 3-MMC 3-Methylmethcathinon, 4-CMC Clephedron. Analytisches Referenzmaterial ausschließlich für Labor- und Forschungszwecke; nicht für den menschlichen Verzehr. Geprüfte Identitäts- und physikalisch-chemische Parameter stehen in der Tabelle der Produkteigenschaften.

Geprüftes Pharmakologie- & Toxikologie-Dossier

alpha-PiHP (alpha-Pyrrolidinoisohexanophenone / alpha-PHiP)

Potent Stimulant (DAT-Selective NDRI) Substituted cathinone / Pyrrolidinophenone (branched isohexanophenone isomer of alpha-PHP)
Geprüfte PubChem- & CAS-Identität C16H23NO · CAS 2181620-71-1 · CID 59809191
Kalibrierte Lieferform Reines Kristall / Analyse-Pulver (≥98 %)
≥98 % analytische Reinheit geprüft 245.37 g/mol
WHO-, PubMed- & PubChem-Quellen 3 · verified sources

Rezeptor-Telemetrie & Wirkmechanismus

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

Branched acyl-chain positional isomer of alpha-PHP (4-methylpentan-1-one backbone, distinct from ring-methylated MPHP) acting as a pure, catecholamine-selective monoamine transporter blocker (NDRI) without releasing activity. WHO 45th ECDD data show pronounced selectivity for DAT (IC50 = 16.5 nM, Ki = 35.7 nM — ~12-fold more potent at uptake blockade and ~16-fold higher affinity than cocaine) and NET (IC50 = 41.4 nM, Ki = 340 nM) while sparing SERT (IC50 > 10,000 nM, Ki > 7,500 nM). High DAT selectivity drives an intense dopaminergic rush and extreme repeated exposure compulsivity.

Biotransformation & Active Metabolites

Expected to follow related pyrrolidinophenone pathways (keto reduction, oxidations, and N-dealkylation); WHO 45th ECDD notes no controlled human clinical pharmacokinetic studies exist.

Zeitliche Pharmakokinetik

Sharp, intensely reinforcing dopaminergic stimulant producing rapid mood elevation, ego inflation, thought acceleration, and heightened libido alongside a very narrow margin before agitation and paranoia.

  1. Onset 30–60 minutes oral (1–2 minutes mucosal; ~1 minute vaporized)
  2. Peak Window 1–2 hours oral (20–45 minutes mucosal)
  3. Total Window 2–5 hours oral (2–4 hours mucosal; 1–3 hours vaporized)
  4. Residual / Half-Life 6–12 hours of residual wakefulness, vasoconstriction, and insomnia across all routes; formal human plasma half-life is unverified.

Active at 3–5 mg orally and 1–3 mg mucosal. Because its intense DAT-driven rush subsides within 2–5 hours while leaving 6–12 hours of residual cardiovascular and adrenergic stimulation, alpha-PiHP triggers relentless compulsive repeated exposure—rapidly escalating into acute paranoid psychosis, severe vasoconstriction, hyperthermia, rhabdomyolysis, and documented single-substance fatalities.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
3–5 mg oral (mucosal: 1–3 mg; vaporized: 1–2 mg)
Cognitive & Sensory

Immediate crisp alertness, subtle focus intensification, and reduced fatigue.

Somatic & Autonomic

Slight heart-rate elevation and appetite suppression.

Light
5–15 mg oral (mucosal: 3–10 mg; vaporized: 2–10 mg)
Cognitive & Sensory

Clear dopaminergic mood lift, talkativeness, task fixation, and confident energy.

Somatic & Autonomic

Moderate pulse and blood-pressure increase, dry mouth, and light sweating.

Common Reference
15–30 mg oral (PMC11051472 10–30 mg; mucosal: 10–25 mg; vaporized: 10–20 mg)
Cognitive & Sensory

Powerful mood-elevating rush, ego inflation, disinhibition, rapid thought acceleration, and strong urge to redose.

Somatic & Autonomic

Marked tachycardia, hypertension, cold extremities from vasoconstriction, jaw tension, and dry mucous membranes.

Strong
30–50 mg oral (mucosal: 25–40 mg; vaporized: 20–30 mg)
Cognitive & Sensory

Compulsive repeated exposure fixation, hyper-vigilance, severe anxiety, logorrhoea, and emerging paranoid ideation.

Somatic & Autonomic

Strong peripheral vasoconstriction, tremors, bruxism, dehydration, and rapid heart rate.

Heavy / Toxic Zone
50+ mg oral (mucosal: 40+ mg; vaporized: 30+ mg)
Cognitive & Sensory

Severe paranoid psychosis, hallucinations, disorientation, delirium, or sudden loss of consciousness.

Somatic & Autonomic

Extreme tachycardia and hypertension, hyperthermia, rhabdomyolysis, respiratory alkalosis, and fatal cardiac arrest.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

16.5 nM DAT and 41.4 nM NET blockade under MAO inhibition triggers rapid, fatal hypertensive crisis and cardiac arrhythmia.

Other stimulants and vasoconstrictors (Cocaine, alpha-PVP, alpha-PHP, MDPHP, NEP, Hexen, MDMA, 25x-NBOMe)

Extreme additive catecholaminergic cardiotoxicity, coronary vasospasm, hyperthermia, and convulsions.

Tramadol and Opioids

Tramadol precipitates seizures; opioids risk fatal delayed respiratory arrest once alpha-PiHP's short 2–4 hour peak drops off.

Hohes Risiko — Vermeiden

Alcohol, Benzodiazepines, Synthetic Cannabinoids, and GHB/GBL

Stimulation masks depressant intoxication until sudden collapse; polydrug combinations feature prominently in European post-mortem alpha-PiHP cases.

Dissociatives (3-MeO-PCP, O-PCE) and Psychedelics

Severely compounds risk of acute delusional mania, panic, and erratic behavioral emergencies.

Vorsicht / Abschwächung

Cannabis

Frequently triggers acute paranoia, hallucinations, and spike in heart rate.

Caffeine

Adds peripheral tremors, tachycardia, and vasoconstriction.

Isomeren- & Strukturvergleich

alpha-PiHP is the branched acyl-chain isomer of alpha-PHP (both C16H23NO, 245.37 g/mol). Compared to alpha-PVP and alpha-PHP, alpha-PiHP displays higher DAT-over-NET selectivity (DAT IC50 16.5 nM vs. NET 41.4 nM) and a shorter primary plateau (2–5 h oral vs. 2–8 h for alpha-PHP), but carries equally fierce—or stronger—anecdotal repeated exposure compulsivity. It is ~10-fold more potent at DAT than NEP.

Stabilität & Lagerung

Form: Odorless white to off-white crystalline solid, fine powder, or rock-like crystal chunks as the monohydrochloride salt (MW 281.8 g/mol). · Soluble in water and PBS (pH 7.2, ~10 mg/mL), DMSO (~5 mg/mL), DMF (~3 mg/mL), ethanol (~3 mg/mL), and methanol (~1 mg/mL).

Store tightly sealed in a cool, dry, light-resistant container.

Cross-Tolerance & Dependence Profile

Extremely high psychological addiction and binge-compulsion liability. Rapid acute tolerance within hours; cross-tolerant with alpha-PVP, alpha-PHP, MDPHP, NEP, and cocaine (halving in 3–7 days, baseline in 1–2 weeks). Multi-day binges reliably provoke stimulant psychosis.

Analytische & toxikologische Monographie

alpha-PiHP (alpha-pyrrolidinoisohexanophenone / alpha-PHiP; 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one; freebase CAS 2181620-71-1, hydrochloride CAS 2705245-60-7, PubChem CID 59809191) is a branched-chain pyrrolidinophenone cathinone supplied as pure analytical crystalline powder or crystals (C16H23NO, 245.37 g/mol). Chemically, it is the branched isohexanophenone chain isomer of alpha-PHP (distinct from ring-methylated MPHP). According to the WHO 45th ECDD Critical Review, alpha-PiHP functions as a pure, catecholamine-selective monoamine transporter blocker without substrate-releasing activity, inhibiting dopamine reuptake at IC50 = 16.5 nM (~12-fold more potent than cocaine) and norepinephrine reuptake at IC50 = 41.4 nM while sparing serotonin reuptake (SERT IC50 > 10,000 nM). Calibrated milligram or volumetric measurement is essential: WHO-compiled oral brackets place threshold effects at 3–5 mg, light stimulation at 5–15 mg, common mood-elevating stimulation at 15–30 mg, strong intensity at 30–50 mg, and heavy overdose risk above 50 mg (mucosal common range is 10–25 mg; vaporized 10–20 mg, with ~1 minute onset and extreme repeated exposure hazard). Oral effects begin in 30–60 minutes and last 2–5 hours (mucosal 2–4 hours), followed by 6–12 hours of residual wakefulness and vasoconstriction. Because the dopaminergic rush fades rapidly relative to adrenergic after-effects, repeated repeated exposure swiftly precipitates sleep deprivation, severe paranoia, rhabdomyolysis, and documented single-substance fatalities. Compared to alpha-PVP and alpha-PHP, alpha-PiHP is slightly shorter-acting and more DAT-selective, while remaining ~10x stronger at DAT than NEP. Never combine alpha-PiHP with MAOIs, cocaine, other cathinones, tramadol, opioids, GHB/GBL, or 25x-NBOMe.

Vergleich in der Gruppe „Cathinon-Derivate“ — ähnliche Verbindungen im Überblick

Direkter Vergleich der chemischen Parameter, Stellungsisomere und verfügbaren Portionsgrößen dieser Stoffklasse:

Verbindung Summenformel Molmasse CAS-Nummer Portionen & Preis ab Blatt
α-PHiP alpha-PiHP Aktuelles Produkt
C16H23NO 245.36 g/mol 2181620-71-1 1 g – 1000 g · 10.00 CHF Aktuelles Produkt
2-CMC Gleiche Stoffklasse (Cathinon-Derivate)
C10H12ClNO 197.66 g/mol 1246911-70-5 1 g – 1000 g · 5.00 CHF Zur Karte →
2-MMC 2-Methylmethcathinon Gleiche Stoffklasse (Cathinon-Derivate)
C11H15NO 177.24 g/mol 1246911-71-6 1 g – 1000 g · 10.00 CHF Zur Karte →
3-CMC Clofedron Gleiche Stoffklasse (Cathinon-Derivate)
C10H12ClNO 197.66 g/mol 1049677-59-9 1 g – 1000 g · 5.00 CHF Zur Karte →
4-CMC Clephedron Gleiche Stoffklasse (Cathinon-Derivate)
C10H12ClNO 197.66 g/mol 1225843-86-6 1 g – 1000 g · 5.00 CHF Zur Karte →

Das könnte Sie auch interessieren